Page last updated: 2024-12-11

triethyllead

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

triethyllead: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6328106
MeSH IDM0055795

Synonyms (8)

Synonym
5224-23-7
triethylplumbane
triethyl lead
triethyllead
660g77bz3j ,
unii-660g77bz3j
plumbane, triethyl-
DTXSID20200282

Research Excerpts

Overview

Triethyllead (TEL) is a CNS neurotoxin producing bizarre neurobehavioral changes.

ExcerptReferenceRelevance
"Triethyllead (TEL) is a CNS neurotoxin producing bizarre neurobehavioral changes. "( Selective inhibition of synaptosomal gamma-aminobutyric acid uptake by triethyllead: role of energy transduction and chloride ion.
Seidman, BC; Verity, MA, 1987
)
1.95

Treatment

Triethyllead treatment reduced the number of neuronal cells with processes. Rats treated with triethyllead exhibit a behavioral supersensitivity to challenge with dopamine agonists at 7 days following administration of TEL.

ExcerptReferenceRelevance
"Triethyllead treatment reduced the number of neuronal cells with processes."( Triethyllead treatment of cultured brain cells. Effect on accumulation of radioactive precursors in galactolipids.
Ammitzbøll, T; Clausen, J; Grundt, IK, 1981
)
2.43
"Rats treated with triethyllead (TEL) exhibit a behavioral supersensitivity to challenge with dopamine agonists at 7 days following administration of TEL. "( Responses of dopaminergic and serotonergic systems to triethyllead intoxication.
DeHaven-Hudkins, DL; Mailman, RB; Schulz, DW; Walsh, TJ,
)
0.71

Toxicity

ExcerptReferenceRelevance
" Although the LD50 values for the two designs were not significantly different, there were significantly more deaths in the 12 mg/kg dosage group within the split-litter design than in the nested design group."( Experimental design considerations: a determinant of acute neonatal toxicity.
Booze, RM; Mactutus, CF, 1985
)
0.27
" Assessment of developmental consequences due to triethyl lead (TEL) intoxication presently included (1) determination of the acute LD50 as 13 +/- 1 mg/kg, and (2) detailed examination of early neurobehavioral sequelae."( Neonatal triethyl lead neurotoxicity in rat pups: initial behavioral observations and quantification.
Annau, Z; Booze, RM; Mactutus, CF; Tilson, HA,
)
0.13
" The single dose LD50 (and 95% CI) following SC administration was found to be 11 mg/kg (7."( Characterization of triethyl lead chloride neurotoxicity in adult rats.
Burne, TA; Mactutus, CF; McLamb, RL; Tilson, HA,
)
0.13

Dosage Studied

ExcerptRelevanceReference
" Referring to the low level of 21 micrograms lead per 100 ml blood and regarding the dose-response relations reported in the literature, the results support the hypothesis of a special neurotoxicity of the alkyllead compounds."( Neurobehavioral effects of a long-term exposure to tetraalkyllead.
Blaszkewicz, M; Kiesswetter, E; Neidhart, B; Seeber, A,
)
0.13
" After dosing with triethyl lead, in vivo inhibition of ALAD only occurred at the high dose, but activation analysis in vitro showed increased ALAD activity to be present at all dose levels in a dose-dependent fashion."( Kinetic parameters of the inhibition of red blood cell aminolevulinic acid dehydratase by triethyl lead and its reversal by dithiothreitol and zinc.
Villeneuve, DC; Yagminas, AP, 1987
)
0.27
" The dose-response curves for D-amphetamine (1."( Acute exposure to triethyl lead enhances the behavioral effects of dopaminergic agonists: involvement of brain dopamine in organolead neurotoxicity.
Dehaven, DL; Schulz, DW; Tilson, HA; Walsh, TJ, 1986
)
0.27
" We directly compared rat pups dosed with triethyl lead (TEL) via both split-litter (representing all dosage groups within a single litter) and nested (all pups randomly assigned to a single litter receive the same dose) designs."( Experimental design considerations: a determinant of acute neonatal toxicity.
Booze, RM; Mactutus, CF, 1985
)
0.27
" The battery of tests was administered on eight occasions, that is, before, at three-week intervals during dosing (PO or IP, five days each week for 15 weeks), and at three and six weeks after dosing."( Assessment of chemicals using a battery of neurobehavioral tests: a comparative study.
Mitchell, CL; Pryor, GT; Tilson, HA; Uyeno, ET,
)
0.13
" In contrast, the group administered TML (3/4 LD50) exhibited a late developing antinocioception which became evident 14 days after dosing and persisted throughout the period of testing."( Organometal-induced antinociception: a time- and dose-response comparison of triethyl and trimethyl lead and tin.
McLamb, RL; Tilson, HA; Walsh, TJ, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (92)

TimeframeStudies, This Drug (%)All Drugs %
pre-199064 (69.57)18.7374
1990's22 (23.91)18.2507
2000's5 (5.43)29.6817
2010's1 (1.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.28 (24.57)
Research Supply Index4.65 (2.92)
Research Growth Index3.93 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.96%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other103 (99.04%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]